Enemeez and Enemeez Plus bowel care

Not just bowel care. Quality Care.

Enemeez® is setting the standard in bowel care.

Request Samples Buy Now!

Enemeez® contains a delivered dose of 283mg of docusate sodium. This non-irritating formula provides fast predictable results typically within 2-15 minutes. Enemeez® products have been shown to be effective for bowel care needs associated with spinal cord injury and disease, multiple sclerosis, traumatic brain injury, spina bifida, stroke and general constipation.

Enemeez® Plus contains an additional 20mg of benzocaine, assisting in the anesthetization of the rectum and lower bowel. The formulation was developed for patients who experience painful bowel movements, hemorrhoids, fissures or autonomic dysreflexia.

Enemeez and Enemeez Plus bowel care

Active Ingredient(s):

Docusate Sodium 283mg

Stool Softener

Inactive Ingredients:

Glycerine and Polyethylene Glycol.

Enemeez and Enemeez Plus bowel care

Active Ingredient(s):

Docusate Sodium 283mg

Stool Softener

Benzocaine 20mg

Topical Anesthetic

Inactive Ingredients:

Glycerine and Polyethylene Glycol.

Fast and Predictable

Enemeez® and Enemeez® Plus work fast, typically within 2-15 minutes. Minimizing your bowel care. Maximizing you life.

Assists with Incontinence

Enemeez® and Enemeez® Plus can virtually eliminate episodes of incontinence with no mucosal discharge, which helps to maintain healthy skin integrity.

Non-irritating Formula

Your comfort is important to us, which is why we developed Enemeez® and Enemeez® Plus to be as gentle as possible. Non-irritating formula. No afterburn.

Easy to Use

Enemeez® and Enemeez® Plus is perfect for patients with reflux issues or nausea. Easy rectal usage.

Please phone Enemeez® customer care department for a listing of hospitals and physicians in your area. Enemeez® customer care is available Monday through Friday, 8am-5pm (Arizona Time) 888.273-9734 extension 208.




Source: 1. Federal Register / Vol. 50, No. 10 / Tuesday, January 15, 1985 / Proposed Rules; pgs 2124-2158. 2. Rehabilitation Nursing (Dunn KL & Galka ML (1994) Comparison of the Effectiveness of Therevac SB and Bisacodyl Suppositories in SCI Patients Bowel Programs, Rehabil Nurs. 19 (6):334-8. 3. Alliance Labs In-house research. Customer Survey Nov. 6, 2009.